Biora Therapeutics, Inc.
BIOR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $21 | $251 | $2,010 | $2,962 |
| - Cash | $15 | $30 | $88 | $92 |
| + Debt | $47 | $129 | $126 | $161 |
| Enterprise Value | $54 | $350 | $2,048 | $3,030 |
| Revenue | $0 | $0 | $1 | $74 |
| % Growth | -98.7% | -75.5% | -98.3% | – |
| Gross Profit | $0 | $0 | $1 | -$19 |
| % Margin | 100% | 100% | 100% | -25.7% |
| EBITDA | -$114 | -$37 | -$165 | -$106 |
| % Margin | -2,851,350% | -12,246.9% | -13,197% | -142.9% |
| Net Income | -$124 | -$38 | -$179 | -$193 |
| % Margin | -3,102,875% | -12,510.5% | -14,316% | -259.1% |
| EPS Diluted | -78.7 | -6.4 | -46.42 | -86.3 |
| % Growth | -1,129.7% | 86.2% | 46.2% | – |
| Operating Cash Flow | -$48 | -$64 | -$167 | -$166 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$5 |
| Free Cash Flow | -$49 | -$65 | -$168 | -$171 |